Food and Drug Administration

Arthritis Advisory Committee

August 7, 1998

Briefing Information

Guidance for Industry: Clinical Development Programs for Drugs, Devices, and Biological Products for the Treatment of Rheumatoid Arthritis (RA), Draft Guidance   pdf